Booz Allen: Too Soon To Say If FDA Process Reforms Are Working
This article was originally published in The Gray Sheet
FDA's device center has implemented all the recommendations Booz Allen Hamilton has made in the past several years to improve the review process, the consulting firm said in its latest independent assessment report. But it is still too early to conclude if the changes have led to significant improvements.
Register for our free email digests: